Develops cancer treatments, including immunotherapies.
Jun 2026Revenue $133M/yrExpenses $96.5M/yr
No trend
Figures by year
Is Agenus profitable?
Yes. In the 12 months to Jun 2026, revenue was $133M and expenses $96.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $114M | $134M | −$20.2M |
| Dec 2024 | $103M | $224M | −$120M |
| Dec 2023 | $156M | $316M | −$160M |
| Dec 2022 | $98.0M | $277M | −$179M |
| Dec 2021 | $296M | $270M | $25.7M |
| Dec 2020 | $88.2M | $205M | −$117M |
| Dec 2019 | $150M | $220M | −$70.1M |
| Dec 2018 | $36.8M | $161M | −$124M |
| Dec 2017 | $42.9M | $147M | −$104M |
| Dec 2016 | $22.6M | $130M | −$107M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.